Cargando…

UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines

The esophageal squamous cell carcinoma (ESCC) is widely known as a highly lethal and poor understood cancer, then requiring the search for novel molecular markers to improve its management and patients survival. Recently, ubiquitin-conjugating enzyme E2C (UBE2C) has been figuring as a prominent tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palumbo, Antonio, Costa, Nathalia Meireles Da, De Martino, Marco, Sepe, Romina, Pellecchia, Simona, Leite de Sousa, Vanessa Paiva, Neto, Pedro Nicolau, Kruel, Cleber Dario, Bergman, Anke, Nasciutti, Luiz Eurico, Fusco, Alfredo, Pinto, Luis Felipe Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323199/ https://www.ncbi.nlm.nih.gov/pubmed/27588470 http://dx.doi.org/10.18632/oncotarget.11674

Ejemplares similares

UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
por: Nicolau-Neto, Pedro, et al.
Publicado: (2018)

Prognosis and Progression of ESCC Patients with Perineural Invasion
por: Xu, Guanghui, et al.
Publicado: (2017)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

Reply: Hookah, opium, and tobacco smoking in relation to ESCC
por: Malekzadeh, R, et al.
Publicado: (2009)

ATF3 suppresses ESCC via downregulation of ID1
por: Li, Jian, et al.
Publicado: (2016)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC
por: Kong, Pengzhou, et al.
Publicado: (2020)

Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC
por: Gao, Hongyun, et al.
Publicado: (2012)

Novel preoperative nutritional assessment tool and prognostic model for ESCC patients
por: Xu, Jinming, et al.
Publicado: (2019)

The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter
por: Liu, Qian, et al.
Publicado: (2019)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

TWIST1 Plays Role in Expression of Stemness State Markers in ESCC
por: Izadpanah, Mohammad Hossein, et al.
Publicado: (2022)

HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
por: Palumbo, Antonio, et al.
Publicado: (2016)

Artificial Intelligence for Detecting and Delineating Margins of Early ESCC Under WLI Endoscopy
por: Liu, Wei, et al.
Publicado: (2022)

Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC
por: Luo, Yuejun, et al.
Publicado: (2022)

Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy
por: Qiao, Yujin, et al.
Publicado: (2022)

The circRNA circADAMTS6 promotes progression of ESCC and correlates with prognosis
por: Bu, Jing, et al.
Publicado: (2022)

Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC
por: Saikia, Manaswita, et al.
Publicado: (2022)

Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC
por: Wang, Qiu‐Yu, et al.
Publicado: (2020)

High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC
por: Yang, Jie, et al.
Publicado: (2018)

ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma
por: Tungekar, Asna, et al.
Publicado: (2018)

Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC
por: Sun, Ying, et al.
Publicado: (2021)

The Impact of the Recurrent Laryngeal Nerve Injury on Prognosis After McKeown Esophagectomy for ESCC
por: Qu, Rirong, et al.
Publicado: (2021)

Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis
por: Tang, Lu, et al.
Publicado: (2020)

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients
por: Cao, Honggang, et al.
Publicado: (2023)

KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription
por: Qin, Mei, et al.
Publicado: (2021)

The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers
por: Meireles Da Costa, Nathalia, et al.
Publicado: (2019)

Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
por: Wang, Yang, et al.
Publicado: (2013)

Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model
por: Essack, Magbubah, et al.
Publicado: (2012)

Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway
por: Li, Fang, et al.
Publicado: (2015)

The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci
por: Zhou, Liqing, et al.
Publicado: (2015)

The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells
por: Zhang, Xiao-Dan, et al.
Publicado: (2018)

Ectopic Expression of Human DPPA2 Gene in ESCC Cell Line Using Retroviral System
por: Khaleghizadeh, Maryam, et al.
Publicado: (2018)

EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway
por: Zhang, Rui, et al.
Publicado: (2020)

An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC
por: Yu, Hongliang, et al.
Publicado: (2021)

Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy
por: Zhou, Wei, et al.
Publicado: (2020)

miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
por: Peng, Jie, et al.
Publicado: (2021)

SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain
por: Liu, Yanqun, et al.
Publicado: (2022)

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
por: Qian, Haili
Publicado: (2022)

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial: A randomized clinical trial of neoadjuvant therapy for ESCC
por: Li, Yong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dpgce06mvc7mmj1vkubvjtaoit